Dexrazoxane

CAS No. 24584-09-6

Dexrazoxane ( ICRF-187;NSC-169780 )

Catalog No. M13714 CAS No. 24584-09-6

A derivative of EDTA that chelates iron and reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 35 Get Quote
50MG 51 Get Quote
100MG 73 Get Quote
500MG 180 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dexrazoxane
  • Note
    Research use only, not for human use.
  • Brief Description
    A derivative of EDTA that chelates iron and reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals.
  • Description
    A derivative of EDTA that chelates iron and reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals; protects the heart against the cardiotoxic side effects of chemotherapeutic drugs.Chemotherapeutic Agents Approved
  • Synonyms
    ICRF-187;NSC-169780
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    Cancer
  • Indication
    Chemotherapeutic

Chemical Information

  • CAS Number
    24584-09-6
  • Formula Weight
    268.27
  • Molecular Formula
    C11H16N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C[C@H](N(C1)CC(NC1=O)=O)CN(C2)CC(NC2=O)=O
  • Chemical Name
    2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lipshultz SE, et al. N Engl J Med. 2004 Jul 8;351(2):145-53.
2. Bjelogrlic SK, et al. Exp Biol Med (Maywood). 2007 Dec;232(11):1414-24.
3. Jones RL, et al. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1311-7.
molnova catalog
related products
  • m-PEG9-SH

    m-PEG9-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.

  • Arjunglucoside I

    Arjunglucoside I has anti-inflammatory activity, it exhibits significant activity against carrageenan-induced paw edema in rat.

  • Phthalic Acid Monooc...

    Used as pharmaceutical intermediates.